Category Archives: Oral Cancer

Are You Wasting Your Time Going to the Gym?

We live in a health-conscious world these days. Countless fitness centers, specialized boutiques and group class crazes, super curated diets, juice bars on every corner and exceptionally aspirational social media profiles proliferate in America and beyond. It’s no question that people want to take care of their health. It’s not a billion-dollar industry without reason.

A recent study involved oral cancer screenings for 85 male and female patients considered to be at risk for oral cancer. All patients were examined in two ways: a conventional clinical examination, consisting of palpation of the face and neck and an unassisted visual inspection of the oral cavity; and an examination of the oral

Early Detection Equals Higher Survival Rates

It is a disease that we give very little thought to, but oral cancer continues to be prevalent with approximately 42,000 Americans being diagnosed with oral cancer or oral pharyngeal cancer this year. It will cause over 8,000 deaths, killing roughly 1 person every hour. Of those 42,000 newly diagnosed individuals, only slightly more than half

After the COE is ‘DONE’

When it comes to patient records it is always best to be able to confirm that a clinical oral examination was done, but writing “COE done” in a chart is NOT enough. The Clinical Oral Examination (COE) should be thoroughly documented with a systematic approach and then placed in the patient’s chart. It is important to build patient history

Why is the Adjunctive Device Important to COE?

Why do you need an adjunctive oral examination device in your practice? The answer to that is straightforward. An adjunctive device utilizing tissue fluorescence visualization picks up where the conventional clinical exam leaves off because it can help to detect far more than the unassisted eye. Adding an adjunctive device to your normal head and

By Donna Domino, Features Editor Dr. Bicuspid February 10, 2014 — The type of cancer stem cells, rather than the number, is a better predictor of the survival of patients with human papillomavirus (HPV)-related head and neck cancer, according to a new study in Cancer (December 30, 2013). Previously, researchers thought patients with HPV-positive tumors